Vancomycin-resistant


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
01 2023
Historique:
pubmed: 11 3 2022
medline: 20 1 2023
entrez: 10 3 2022
Statut: ppublish

Résumé

To analyze the spread of a novel sequence type (ST1478) of vancomycin-resistant Retrospective chart review of patients identified as having ST1478 VRE bloodstream infection. Canadian hospitals that participate in the Canadian Nosocomial Infection Surveillance Program (CNISP). From 2013 to 2018, VRE bloodstream isolates collected from participating CNISP hospitals were sent to the National Microbiology Laboratory (NML). ST1478 isolates were identified using multilocus sequence typing, and whole-genome sequencing was performed. Patient characteristics and location data were collected for patients with ST1478 bloodstream infection (BSI). The sequence and patient location information were used to generate clusters of infections and assess for intrahospital and interhospital spread. ST1478 VRE BSI occurred predominantly in a small number of hospitals in central and western Canada. Within these hospitals, infections were clustered on certain wards, and isolates often had <20 single-nucleotide variants (SNV) differences from one another, suggesting a large component of intrahospital spread. Furthermore, some patients with bloodstream infections were identified as moving from one hospital to another, potentially having led to interhospital spread. Genomic analysis of all isolates revealed close relatedness between isolates at multiple different hospitals (<20 SNV) not predicted from our epidemiologic data. Both intrahospital and regional interhospital spread have contributed to the emergence of VRE ST1478 infections across Canada. Whole-genome sequencing provides evidence of spread that might be missed with epidemiologic investigation alone.

Identifiants

pubmed: 35264277
pii: S0899823X22000071
doi: 10.1017/ice.2022.7
doi:

Substances chimiques

Vancomycin 6Q205EH1VU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-23

Auteurs

David R Kleinman (DR)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Robyn Mitchell (R)

Public Health Agency of Canada, Ottawa, Ontario, Canada.

Melissa McCracken (M)

Antimicrobial Resistance and Nosocomial Infections, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Susy S Hota (SS)

Infection Prevention and Control Department, University Health Network, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, TorontoOntario, Canada.

George R Golding (GR)

Antimicrobial Resistance and Nosocomial Infections, One Health Division, Surveillance, Reference and Science Directorate of the National Microbiology Laboratory Branch, Winnipeg, Manitoba, Canada.

Stephanie W Smith (SW)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH